Latest round

Series A

Last raised

Jan 2026

Total raised

$26M

Investors

9

About Evaro

, dba Evaro, operates as a healthcare technology company that offers digital health solutions and healthcare accessibility. Thuria Wenbar (CEO) and Oskar Wendowski (CPO) are the co-founders of the company. Evaro generates revenue through a B2B pharmaceutical infrastructure-as-a-service model, enabling consumer brands to integrate prescription medication services seamlessly into their offerings.

Who invested in Evaro

9 investors across 2 rounds

See all investors in Evaro

Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.

Funding rounds

  1. Series A

    Jan 27, 2026

    Amount

    $24M

    Investors

    Locked

  2. Seed

    Jan 26, 2023

    Amount

    $1.4M

    Investors

    Locked

Questions about Evaro

Who invested in Evaro?

Evaro has 9 investors on record across 2 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.

How much funding has Evaro raised?

Evaro has raised 2 venture rounds. Sign up free to see how much each round raised and the total.

When did Evaro last raise money?

Evaro's most recent round on record is a Series A, in Jan 2026.

What does Evaro do?

, dba Evaro, operates as a healthcare technology company that offers digital health solutions and healthcare accessibility.

Where is Evaro headquartered?

Evaro is headquartered in Norwich, UK.

Which VCs invest in companies like Evaro?

Among active investors with capital left to deploy, Index Ventures, Forbion, European Investment Bank and Highland Europe back healthcare it companies at Evaro's stage. Their profiles are linked below.

Raising like Evaro? Find the right VCs.

Capital Atlas matches your startup to active investors by stage, sector and region.

Free to start. Upgrade when you're ready to reach out.